DrugPatentWatch Database Preview

Alpharma Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA, and when can generic versions of ALPHARMA drugs launch?

ALPHARMA has sixty-three approved drugs.

There are nine US patents protecting ALPHARMA drugs.

There are forty-nine patent family members on ALPHARMA drugs in twenty-two countries and six supplementary protection certificates in two countries.

Summary for Alpharma

International Patents:	49
US Patents:	9
Tradenames:	45
Ingredients:	42
NDAs:	63
Patent Litigation for Alpharma:	See patent lawsuits for Alpharma

Drugs and US Patents for Alpharma

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	MYKINAC	nystatin	CREAM;TOPICAL	062387-001	Jul 29, 1982		DISCN	No	No
Alpharma Us Pharms	ISOPROTERENOL HYDROCHLORIDE	isoproterenol hydrochloride	AEROSOL, METERED;INHALATION	085904-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Alpharma Us Pharms	TRIMETH/SULFA	sulfamethoxazole; trimethoprim	SUSPENSION;ORAL	072398-001	May 23, 1988		DISCN	No	No
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-002	Aug 13, 2009		RX	Yes	No	8,685,444		Y
Alpharma Us Pharms	HYDRAMINE	diphenhydramine hydrochloride	SYRUP;ORAL	070205-001	Jan 28, 1986		DISCN	No	No

Expired US Patents for Alpharma

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-006	Aug 13, 2009	5,202,128
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-002	Aug 13, 2009	5,202,128
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	4,620,974
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-001	Aug 13, 2009	5,202,128
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-003	Aug 13, 2009	5,202,128

Paragraph IV (Patent) Challenges for ALPHARMA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Capsules	30 mg/1.2 mg, 50 mg/2 mg and 80 mg/3.2 mg		2010-05-28
	Extended-release Capsules	100 mg/4 mg		2010-05-03
	Extended-release Capsules	60 mg/2.4 mg		2010-05-25

International Patents for Alpharma Drugs

Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2007149438
Denmark	2484346
Portugal	2034975
Canada	2655835
Slovenia	2484346

Supplementary Protection Certificates for Alpharma Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C/GB12/047	United Kingdom		PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
C/GB10/012	United Kingdom		PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C0012	France		PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C0038	France		PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C/GB98/013	United Kingdom		PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Alpha Thera
• Alpharma
• Alpharma Pharms
• Alpharma Us Pharms